SciELO - Scientific Electronic Library Online

vol.48 número1Carcinoma medular de tireóide: aspectos moleculares, clínico-oncológicos e terapêuticosIodo radioativo no manejo do hipertireoidismo da doença de Graves índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados




Links relacionados


Arquivos Brasileiros de Endocrinologia & Metabologia

versão On-line ISSN 1677-9487


ROMALDINI, João Hamilton; SGARBI, José Augusto  e  FARAH, Chady Satt. Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism. Arq Bras Endocrinol Metab [online]. 2004, vol.48, n.1, pp.147-158. ISSN 1677-9487.

Subclinical hypothyroidism (SHT) and subclinical hyperthyroidism (SCH) are defined as normal serum free T4 and T3 levels associated with elevated (SHT) or subnormal (SCH) serum TSH levels, respectively. Symptoms and signs of thyroid dysfunction are scarce. The prevalence is low. In SHT, total cholesterol and LDL-C are modestly elevated and levothyroxine may influence the lipids levels. There is decreased cardiac contractility and increased peripheral vascular resistance that improve with treatment. SCH is associated with atrial fibrillation, increased cardiac contractility and left ventricular mass, diastolic and systolic dysfunction that can be reversed with beta-adrenergic antagonists. Bone density is reduced in SCH. Depression, panic disorders and alterations in cognitive testing are frequent in SHT. Treatment of SHT is recommended for serum TSH levels greater than 8mU/L and presence of thyroid antibodies. Endogenous SCH should be treated for serum TSH levels less than 0.1mU/L, in the presence of symptoms and in elderly patents.

Palavras-chave : Thyroxin; SHT; Hypothyroidism; Hyperthyroidism; Levothyroxin.

        · resumo em Português     · texto em Português     · Português ( pdf )


Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons